GEOF SA
The score of GEOF shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -11 % Total assets -20 %
Accounts of the company itself (not consolidated).
The full file covers 17 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
GEOF's annual accounts
Filed annual accounts
- Year ended 31 Mar 2025filed on 21 Oct 2025
- Year ended 31 Mar 2024filed on 22 Oct 2024
- Year ended 31 Mar 2023filed on 26 Oct 2023
- Year ended 31 Mar 2022filed on 21 Oct 2022
- Year ended 31 Mar 2021filed on 04 Nov 2021
GEOF's financial analysis
- Solvency62.2%sector median: 40.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of GEOF
GEOF's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0474.704.538
- VAT number
- BE0474704538
- Peppol
- Registered · 0208:0474704538 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 27 Apr 2001
- Registered office
- 6000 Charleroi
- Latest accounts
- 2025 · filed on 21 Oct 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
GEOF (SA) has been based in Charleroi since 2001, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 41,098 € and equity of €1.31m; its revenue is not published. Its solvency stands at 62.2%, above the median of its sector (40.1%).
Companies similar to GEOF
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Gerpinnes Pharma Retail sale of pharmaceutical products Gerpinnes · balance sheet €2.08m
- Nicolas PUTOIS Retail sale of pharmaceutical products Chaudfontaine · balance sheet €2.14m
- Marjolein Vanderheyden Retail sale of pharmaceutical products Bocholt · balance sheet €2.14m
- Dstm Holding Retail sale of pharmaceutical products Léglise · balance sheet €2.14m
- DR Pharma Retail sale of pharmaceutical products Bièvre · balance sheet €2.15m
- Apotheek Pharmavie Retail sale of pharmaceutical products Assenede · balance sheet €2.18m
- Stef DE MAN Retail sale of pharmaceutical products Sint-Truiden · balance sheet €2.02m
Frequently asked questions about GEOF
What is the revenue of GEOF?
GEOF files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of GEOF?
In Belgium, the VAT number is the company number prefixed with BE: BE0474704538 for GEOF, if the company is VAT-registered. Its company number (CBE) is 0474.704.538.
Where is the registered office of GEOF?
According to the CBE register, the registered office of GEOF is in 6000 Charleroi.
What is the equity of GEOF?
At the close of the 2025 financial year, the equity of GEOF amounts to 1,308,815 €, a solvency of 62.2% of total assets.
Who manages GEOF?
The register lists 2 active mandates at GEOF. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of GEOF
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →